WILSON KAREN J — SEC insider filings

SEC reporting owner CIK 1267490. 16 insider filings on record with FilingPulse; latest filed 2026-09-02.

Transaction summary — filings shown

Covers all 16 filings on record, filed 2020-08-27 to 2026-09-02. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.

By issuer — same filings

Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.

IssuerRole (as filed)FilingsPurchases (P)Sales (S)Other legs
Serina Therapeutics, Inc. (SER)Director54 legs · 30,100 sh · $54,750—3
Elicio Therapeutics, Inc. (ELTX)Director7——8
LAVA Therapeutics NV (LVTX)Director2——3
Vaxart, Inc. (VXRT)Director2——2

Insider filings — WILSON KAREN J

FiledFormIssuerReported transactionsSource
2026-09-024Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 21,750 (derivative) @ $0EDGAR
2026-06-224Serina Therapeutics, Inc. (SER)Grant/award (A): 15,250 (derivative) @ $0EDGAR
2026-06-154Serina Therapeutics, Inc. (SER)Purchase (P): 5,100 @ $1.75 · Purchase (P): 5,000 @ $1.77EDGAR
2026-05-264Serina Therapeutics, Inc. (SER)Purchase (P): 10,000 @ $1.77 · Purchase (P): 10,000 @ $1.93EDGAR
2025-11-174LAVA Therapeutics NV (LVTX)Disposition to issuer (D): 10,000 · Disposition to issuer (D): 33,390 (derivative) @ $0EDGAR
2025-11-104Serina Therapeutics, Inc. (SER)Grant/award (A): 10,000 (derivative) @ $0EDGAR
2025-05-204Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 7,900 (derivative) @ $0EDGAR
2025-02-184LAVA Therapeutics NV (LVTX)Grant/award (A): 33,390 (derivative) @ $0EDGAR
2025-01-154Serina Therapeutics, Inc. (SER)Grant/award (A): 40,000 (derivative) @ $0EDGAR
2024-11-254Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 4,100 (derivative) @ $0EDGAR
2023-12-294Elicio Therapeutics, Inc. (ELTX)Grant/award (A): 4,100 (derivative) @ $0EDGAR
2022-06-134Angion Biomedica Corp. (ANGN)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-06-174Vaxart, Inc. (VXRT)Grant/award (A): 15,097 (derivative) @ $0EDGAR
2021-03-104Angion Biomedica Corp. (ANGN)Grant/award (A): 15,000 (derivative) @ $0EDGAR
2021-02-114Angion Biomedica Corp. (ANGN)Conversion (C): 18,718 @ $11.57 · Conversion (C) @ $0EDGAR
2020-08-274Vaxart, Inc. (VXRT)Grant/award (A): 65,700 (derivative) @ $0EDGAR

FilingPulse's Form 4 archive currently extends back to 2020-08-26 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.

Need this as JSON? GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1267490 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs